ALTERED CELLULAR ENERGETICS AND DYSREGULATION OF NK CELLS IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Yadav, Pushpa [1 ]
Kumari, Anupama [1 ]
Pahwa, Prabhjyoti [1 ]
Rehan, Aesha [1 ]
Pamecha, Viniyendra [1 ]
Sarin, Shiv Kumar [1 ]
Trehanpati, Nirupma [1 ]
机构：
[1] Inst Liver & Biliary Sci, Delhi, India
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1965
引用
收藏
页码：S1490 / S1491
页数：2
相关论文
共 50 条
  • [21] Sorafenib increases the percentage and cytotoxicity of circulating NK cells in hepatocellular carcinoma patients
    Hu, J.
    Xia, D.
    Zhang, M.
    Wang, E.
    Liu, L.
    Wang, Q.
    Bai, W.
    Tie, J.
    Li, X.
    Yuan, J.
    Niu, J.
    Li, K.
    He, C.
    Guo, W.
    Chen, H.
    Yuan, X.
    Yu, T.
    Wang, Z.
    Luo, B.
    Han, N.
    Zhu, Y.
    Zhang, Z.
    Yin, Z.
    Fan, D.
    Yang, K.
    Han, G.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S665 - S665
  • [22] DEVELOPMENT OF GPC3-CAR-NK CELLS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Yang, Lei
    Liu, Dongfang
    Robertson, Keith
    Xi, Yibo
    Liu, Chen
    HEPATOLOGY, 2022, 76 : S1314 - S1315
  • [23] Metabolic and functional recovery of tumor infiltrating NK-cells in Hepatocellular Carcinoma
    Zecca, A.
    Barili, V.
    Dalla Valle, R.
    Rizzo, D.
    Olivani, A.
    Biasini, E.
    Ferrari, C.
    Cariani, E.
    Missale, G.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E12 - E12
  • [24] Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma
    Tao, L.
    Wang, S.
    Yang, L.
    Jiang, L.
    Li, J.
    Wang, X.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (02): : 161 - 170
  • [25] ENGINEERING CAR-NK CELLS SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN IN HEPATOCELLULAR CARCINOMA
    Badami, E.
    Busa, R.
    Mateus, B. G. Douradinha
    Conaldi, P.
    CYTOTHERAPY, 2021, 23 (05) : S93 - S93
  • [26] Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells
    Tsunematsu, Hinako
    Tatsumi, Tomohide
    Kohga, Keisuke
    Yamamoto, Masashi
    Aketa, Hiroshi
    Miyagi, Takuya
    Hosui, Atsushi
    Hiramatsu, Naoki
    Kanto, Tatsuya
    Hayashi, Norio
    Takehara, Tetsuo
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 356 - 364
  • [27] Defective DNAM-1 mediated cytotoxicity in NK cells infiltrating hepatocellular carcinoma
    Oliviero, B.
    Mantovani, S.
    Mele, D.
    Donadon, M.
    Soldani, C.
    Torzilli, G.
    Santambrogio, R.
    Opocher, E.
    Chiellino, S.
    Porta, C.
    Mondelli, M. U.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S667 - S667
  • [28] Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
    Cai, Lun
    Zhang, Zheng
    Zhou, Lin
    Wang, Haiyan
    Fu, Junliang
    Zhang, Shuye
    Shi, Min
    Zhang, Hui
    Yang, Yongping
    Wu, Hao
    Tien, Po
    Wang, Fu-Sheng
    CLINICAL IMMUNOLOGY, 2008, 129 (03) : 428 - 437
  • [29] Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells in vitro
    Khan, Ajab
    Fan, Kuohai
    Sun, Na
    Yin, Wei
    Sun, Yaogui
    Sun, Panpan
    Jahejo, Ali Raza
    Li, Hongquan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 140 : 1249 - 1259
  • [30] MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine
    Lyra-Gonzalez, Ivan
    Flores-Fong, Laura E.
    Gonzalez-Garcia, Ignacio
    Medina-Preciado, David
    Armendariz-Borunda, Juan
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (11) : 1530 - 1540
12345